Published in Circulation on February 16, 1999
Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients. JACC Cardiovasc Imaging (2014) 1.44
Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol (2004) 0.92
Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol (2004) 0.89
Sex differences in the diagnostic evaluation of coronary artery disease. J Nucl Cardiol (2011) 0.83
Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes. Quant Imaging Med Surg (2014) 0.83
The prognostic role of stress echocardiography in a contemporary population and the clinical significance of limited apical ischaemia. Echo Res Pract (2016) 0.80
Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischaemia with SPECT imaging: a randomized, placebo-controlled trial. Eur J Nucl Med Mol Imaging (2011) 0.79
Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation. Heart (2004) 0.78
Prognostic value of normal stress echocardiography in obese patients. J Obes (2014) 0.78
Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography. Cardiovasc Ultrasound (2007) 0.78
Long-term prognostic value of dobutamine stress echocardiography in diabetic patients with limited exercise capability: a 13-year follow-up study. Diabetes Care (2012) 0.78
Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation. Curr Cardiol Rev (2009) 0.77
Prognostic implications of negative dobutamine stress echocardiography in African Americans compared to Caucasians. Cardiovasc Ultrasound (2008) 0.77
Left ventricular systolic function deterioration during dobutamine stress echocardiography as an early manifestation of diabetic cardiomyopathy and reversal by optimized therapeutic approach. Int J Cardiovasc Imaging (2011) 0.76
The clinical use of stress echocardiography in ischemic heart disease. Cardiovasc Ultrasound (2017) 0.75
The effects of beta-blockers on dobutamine-atropine stress echocardiography: early protocol versus standard protocol. Cardiovasc Ultrasound (2006) 0.75
Prognostic value of dobutamine stress echocardiography in octogenarians. Int J Cardiovasc Imaging (2010) 0.75
Long term follow up after deferral of revascularisation in patients with intermediate coronary stenoses and negative dobutamine stress echocardiography. Heart (2002) 0.75
The neutrophil to lymphocyte ratio improves the positive predictive value of dobutamine stress echocardiography. Int J Clin Exp Med (2015) 0.75
Dipyridamole stress echocardiography stratifies outcomes of asymptomatic patients with recent myocardial revascularization. Int J Cardiovasc Imaging (2007) 0.75
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet (1996) 8.50
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med (1999) 5.21
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation (1991) 3.25
Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet (1985) 3.13
Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J (2000) 3.07
Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation (2001) 3.03
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet (1988) 2.90
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet (1997) 2.80
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. Eur Heart J (2004) 2.67
Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol (1986) 2.58
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53
Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. Eur Heart J (2003) 2.49
Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation (1993) 2.32
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
Concern Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J (2001) 2.26
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med (1999) 2.10
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation (1995) 2.08
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol (1996) 2.07
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J (2002) 2.06
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. Circulation (1996) 2.03
Left ventricular hypertrophy screening using a hand-held ultrasound device. Eur Heart J (2002) 1.95
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol (1996) 1.91
Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J (2002) 1.87
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors. J Am Coll Cardiol (1992) 1.82
Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation (1995) 1.81
Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol (1997) 1.74
Management of patients with heart failure in clinical practice: differences between men and women. Heart (2007) 1.73
Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol (1997) 1.72
Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med (2001) 1.70
Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (1996) 1.70
Guidelines from the Working Group. Recommendations for performing transesophageal echocardiography. Eur J Echocardiogr (2001) 1.69
Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J (2004) 1.66
Incidence and follow-up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol (1995) 1.64
Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? J Am Coll Cardiol (1996) 1.63
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. Eur Heart J (2000) 1.62
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol (1999) 1.60
Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat? Eur Heart J (2001) 1.60
ECG-gated versus nongated three-dimensional intracoronary ultrasound analysis: implications for volumetric measurements. Cathet Cardiovasc Diagn (1998) 1.60
Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey. J Neurol Neurosurg Psychiatry (2008) 1.59
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J (2004) 1.59
Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. J Am Coll Cardiol (1986) 1.57
Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. Eur Heart J (2000) 1.55
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain. Heart (2008) 1.55
Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J (2000) 1.55
Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J (1996) 1.54
QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. Br Heart J (1993) 1.54
Advantages of colour flow imaging in the diagnosis of left ventricular pseudoaneurysm. Br Heart J (1989) 1.54
COPD and cancer mortality: the influence of statins. Thorax (2009) 1.53
No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum (2009) 1.53
The Cardiac Infarction Injury Score as a predictor for long-term mortality in survivors of a myocardial infarction. Eur Heart J (1998) 1.52
Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. Eur Heart J (1996) 1.52
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J (1996) 1.52
Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification. Eur J Vasc Endovasc Surg (2009) 1.51
Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation (1997) 1.51
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. Br Heart J (1992) 1.50
Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart (2006) 1.50
Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol (2001) 1.48
Cardiac magnetic resonance imaging findings in patients with right ventricular outflow tract premature contractions. Eur Heart J (1997) 1.48
Two-dimensional echocardiographic analysis of the dynamic geometry of the left ventricle: the basis for an improved model of wall motion. J Am Soc Echocardiogr (1990) 1.46
Secundum atrial septal defect is a dynamic three-dimensional entity. Am Heart J (1999) 1.46
Prospective study of early discharge after acute myocardial infarction (SHORT) Eur Heart J (2000) 1.46